Free Trial

DiaMedica Therapeutics (DMAC) Short Interest Ratio & Short Volume

→ Warren Buffett's 'mystery stock' (From Stansberry Research) (Ad)
Free DMAC Stock Alerts
$3.10
-0.07 (-2.21%)
(As of 12:37 PM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media

DiaMedica Therapeutics Short Interest Data

Current Short Interest
182,000 shares
Previous Short Interest
175,400 shares
Change Vs. Previous Month
+3.76%
Dollar Volume Sold Short
$469,560.00
Short Interest Ratio
4.3 Days to Cover
Last Record Date
April 30, 2024
Outstanding Shares
37,960,000 shares
Percentage of Shares Shorted
0.48%
Today's Trading Volume
4,094 shares
Average Trading Volume
41,431 shares
Today's Volume Vs. Average
10%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling DiaMedica Therapeutics ?

Sign up to receive the latest short interest report for DiaMedica Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

DMAC Short Interest Over Time

DMAC Days to Cover Over Time

DMAC Percentage of Float Shorted Over Time

DiaMedica Therapeutics Short Interest History

Export to Excel
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/2024182,000 shares $469,560.00 +3.8%N/A4.3 $2.58
4/15/2024175,400 shares $419,206.00 -13.3%N/A4.4 $2.39
3/31/2024202,200 shares $560,094.00 -4.9%N/A4.8 $2.77
3/15/2024212,600 shares $644,178.00 +8.3%N/A5 $3.03
2/29/2024196,300 shares $588,900.00 +3.7%N/A4.7 $3.00
2/15/2024189,300 shares $567,900.00 -3.3%N/A4.4 $3.00
1/31/2024195,700 shares $551,874.00 -3.1%N/A4 $2.82
1/15/2024202,000 shares $603,980.00 +7.0%N/A4 $2.99
12/31/2023188,800 shares $536,192.00 -2.2%N/A3.8 $2.84
12/15/2023193,100 shares $531,025.00 +5.4%N/A3.7 $2.75
11/30/2023183,300 shares $447,252.00 -24.9%N/A3.1 $2.44
11/15/2023244,200 shares $598,290.00 0.0%N/A4 $2.45
10/31/2023244,300 shares $532,574.00 +11.5%N/A4 $2.18
10/15/2023219,100 shares $449,155.00 -1.1%N/A2.9 $2.05
9/30/2023221,500 shares $571,470.00 +0.7%N/A2.3 $2.58
9/15/2023219,900 shares $712,476.00 -0.8%N/A1.8 $3.24
8/31/2023221,700 shares $654,015.00 -9.4%N/A1.5 $2.95
8/15/2023244,600 shares $725,239.00 -10.6%N/A1.5 $2.97
7/31/2023273,500 shares $924,430.00 -65.7%N/A1.6 $3.38
7/15/2023796,100 shares $3.01 million +11.6%4.5%5.4 $3.78
6/30/2023713,600 shares $3.08 million +910.8%4.0%5.4 $4.32
6/15/202370,600 shares $224,508.00 +7.1%0.4%0.7 $3.18
5/31/202365,900 shares $179,907.00 -21.2%0.4%1.1 $2.73
5/15/202383,600 shares $166,196.80 -9.0%0.5%1.9 $1.99
4/30/202391,900 shares $149,797.00 -5.7%0.5%3.4 $1.63
4/15/202397,400 shares $155,840.00 +6.5%0.6%3.4 $1.60
3/31/202391,500 shares $139,995.00 +55.6%0.5%2.9 $1.53
3/15/202358,800 shares $104,664.00 +44.8%0.4%1.5 $1.78
2/28/202340,600 shares $70,238.00 -1.7%0.3%0.7 $1.73
2/15/202341,300 shares $62,363.00 +22.6%0.3%0.7 $1.51
1/31/202333,700 shares $45,495.00 -57.8%0.2%0.5 $1.35
1/15/202379,800 shares $130,872.00 -6.5%0.5%1.2 $1.64
12/30/202285,300 shares $134,782.53 +113.8%0.5%1.3 $1.58
12/15/202239,900 shares $60,249.00 -7.0%0.2%0.6 $1.51
11/30/202242,900 shares $51,051.00 +24.4%0.2%0.7 $1.19
11/15/202234,500 shares $39,330.00 -35.0%0.2%0.6 $1.14
10/31/202253,100 shares $62,658.00 -47.5%0.3%0.9 $1.18
10/15/2022101,200 shares $153,824.00 +245.4%0.6%1.9 $1.52
9/30/202229,300 shares $36,332.00 -61.7%0.2%0.4 $1.24
9/15/202276,500 shares $110,925.00 +153.3%0.4%0.5 $1.45
Warren Buffett's "mystery stock" (Ad)

WARNING: Read This Before the Next Fed Meeting Investors are looking to the Fed with high hopes for interest rate relief. Unfortunately, many have no idea there's another major story unfolding right now, one that could be worth $40 trillion.

This Wall Street millionaire just stepped forward with all the details, and how it could make some
8/31/202230,200 shares $53,454.00 -43.6%0.2%0.2 $1.77
8/15/202253,500 shares $96,835.00 -0.2%0.3%0.4 $1.81
7/31/202253,600 shares $88,440.00 +10.7%0.3%0.4 $1.65
7/15/202248,400 shares $61,952.00 -8.2%0.3%0.4 $1.28
6/30/202252,700 shares $106,454.00 +5.0%0.3%0.4 $2.02
6/15/202250,200 shares $110,440.00 -1.6%0.3%1.1 $2.20
5/31/202251,000 shares $123,930.00 -50.3%N/A1.2 $2.43
5/15/2022102,700 shares $250,588.00 +85.4%N/A2.3 $2.44
4/30/202255,400 shares $128,528.00 +62.5%N/A1.2 $2.32
4/15/202234,100 shares $79,112.00 +5.9%N/A0.6 $2.32
3/31/202232,200 shares $80,500.00 -45.8%N/A0.5 $2.50
3/15/202259,400 shares $136,620.00 -26.0%N/A0.7 $2.30
2/28/202280,300 shares $211,189.00 -23.5%N/A0.7 $2.63
2/15/2022104,900 shares $325,190.00 +21.6%N/A0.9 $3.10
1/31/202286,300 shares $223,517.00 +14.9%0.5%0.6 $2.59
1/15/202275,100 shares $253,838.00 +22.1%0.4%0.4 $3.38
12/31/202161,500 shares $229,395.00 -22.5%0.3%0.4 $3.73
12/15/202179,300 shares $307,684.00 +55.8%0.4%0.4 $3.88
11/30/202150,900 shares $190,366.00 -26.9%0.3%0.3 $3.74
11/15/202169,600 shares $280,488.00 -21.5%0.4%0.3 $4.03
10/29/202188,700 shares $350,365.00 -7.9%0.6%0.4 $3.95
10/15/202196,300 shares $394,830.00 +62.4%0.6%0.5 $4.10
9/30/202159,300 shares $237,793.00 +9.6%N/A0.3 $4.01
9/15/202154,100 shares $209,367.00 +29.7%0.3%0.2 $3.87
8/31/202141,700 shares $179,310.00 +85.3%0.2%0.1 $4.30
8/13/202122,500 shares $69,750.00 -59.4%0.1%0.1 $3.10
7/30/202155,400 shares $191,130.00 -23.9%0.3%0.2 $3.45
7/15/202172,800 shares $264,992.00 -47.5%0.4%0.3 $3.64
6/30/2021138,700 shares $617,215.00 -26.9%0.8%0.6 $4.45
6/15/2021189,800 shares $1.64 million +27.7%1.1%1.9 $8.63
5/28/2021148,600 shares $1.10 million -6.8%0.9%1.6 $7.41
5/14/2021159,400 shares $1.03 million -2.8%N/A1.5 $6.47
4/30/2021164,000 shares $1.56 million -12.3%N/A1.4 $9.50
4/15/2021187,000 shares $1.78 million +8.4%N/A1.5 $9.54
3/31/2021172,500 shares $1.58 million +10.0%N/A1.2 $9.18
3/15/2021156,800 shares $1.53 million +34.5%N/A0.8 $9.74
2/26/2021116,600 shares $1.08 million +40.5%N/A0.6 $9.25
2/12/202183,000 shares $728,740.00 -10.9%N/A0.3 $8.78
1/29/202193,100 shares $722,456.00 +17.0%N/A0.4 $7.76
1/15/202179,600 shares $780,876.00 -19.7%N/A0.4 $9.81
12/31/202099,100 shares $969,198.00 +145.9%N/A0.5 $9.78
12/15/202040,300 shares $257,517.00 +75.2%N/A0.2 $6.39
11/30/202023,000 shares $132,250.00 +10.1%N/A0.2 $5.75
11/15/202020,900 shares $87,362.00 -34.7%N/A0.3 $4.18
10/30/202032,000 shares $132,160.00 +33.3%N/A0.7 $4.13
10/15/202024,000 shares $114,000.00 +8.1%N/A0.4 $4.75
9/30/202022,200 shares $94,128.00 +7.8%N/A0.4 $4.24
9/15/202020,600 shares $88,786.00 -21.1%N/A0.4 $4.31
8/31/202026,100 shares $123,975.00 +12.5%N/A0.4 $4.75
8/14/202023,200 shares $124,120.00 +373.5%N/A0.3 $5.35
Boost your retirement with these AI payouts (Ad)

BREAKING: New "Formula" Could Lead to Huge AI Payouts When you click here and see what Elon Musk's new invention does… Investors — including multiple billionaires — are now tapping into a unique AI secret to pocket huge, consistent payouts.

Starting today, you could siphon a new stream of income from this $3 billion pool of cash.
7/31/20204,900 shares $29,155.00 -54.2%N/A0.1 $5.95
7/15/202010,700 shares $63,130.00 -15.8%N/A0.1 $5.90
6/30/202012,700 shares $85,344.00 -35.2%N/A0.2 $6.72
6/15/202019,600 shares $91,728.00 -14.0%0.2%0.3 $4.68
5/29/202022,800 shares $105,336.00 -33.9%0.2%0.4 $4.62
5/15/202034,500 shares $155,250.00 +155.6%0.3%0.6 $4.50
4/30/202013,500 shares $54,675.00 +82.4%0.1%0.3 $4.05
4/15/20207,400 shares $23,236.00 +124.2%0.1%0.2 $3.14
3/31/20203,300 shares $12,045.00 -10.8%0.0%0.1 $3.65
3/13/20203,700 shares $10,952.00 -30.2%0.0%0.1 $2.96
2/28/20205,300 shares $12,243.00 -51.4%0.1%0.1 $2.31
2/14/202010,900 shares $44,581.00 +29.8%0.1%0.2 $4.09
1/31/20208,400 shares $42,504.00 -46.5%0.1%0.2 $5.06
1/15/202015,700 shares $69,237.00 -56.6%0.2%0.4 $4.41
12/31/201936,200 shares $151,678.00 +46.6%0.4%0.8 $4.19

DMAC Short Interest - Frequently Asked Questions

What is DiaMedica Therapeutics' current short interest?

Short interest is the volume of DiaMedica Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 182,000 shares of DMAC short. Learn More on DiaMedica Therapeutics' current short interest.

What is a good short interest ratio for DiaMedica Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. DMAC shares currently have a short interest ratio of 4.0. Learn More on DiaMedica Therapeutics's short interest ratio.

Which institutional investors are shorting DiaMedica Therapeutics?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of DiaMedica Therapeutics: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is DiaMedica Therapeutics' short interest increasing or decreasing?

DiaMedica Therapeutics saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 182,000 shares, an increase of 3.8% from the previous total of 175,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does DiaMedica Therapeutics' short interest compare to its competitors?

Here is how the short interest of companies in the sector of "medical" compare to DiaMedica Therapeutics: Coya Therapeutics, Inc. (1.41%), Vistagen Therapeutics, Inc. (4.86%), Nuvectis Pharma, Inc. (13.15%), FibroGen, Inc. (6.96%), Adagene Inc. (0.04%), Immunic, Inc. (3.13%), Amylyx Pharmaceuticals, Inc. (18.07%), Abeona Therapeutics Inc (12.94%), OptiNose, Inc. (5.24%), Rezolute, Inc. (0.78%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks.

What does it mean to sell short DiaMedica Therapeutics stock?

Short selling DMAC is an investing strategy that aims to generate trading profit from DiaMedica Therapeutics as its price is falling. DMAC shares are trading down $0.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against DiaMedica Therapeutics?

A short squeeze for DiaMedica Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of DMAC, which in turn drives the price of the stock up even further.

How often is DiaMedica Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including DMAC, twice per month. The most recent reporting period available is April, 30 2024.



More Short Interest Resources from MarketBeat

Related Companies:
Short Interest Tools:
This page (NASDAQ:DMAC) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!
Priority Gold
Does this make you sick?
Allegiance Gold
Dems have chosen Biden replacement?
Paradigm Press
The Overlooked Retirement Asset You Probably Don’t Own
Crypto 101 Media
This Apple-like Innovator is Revolutionizing Healthcare
Wall Street Star
**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1!
Huge Alerts
This Could be Your “Big Money” AI Moment
InvestorPlace
Digitizing the $11T commodities sector with one tiny stock
Resource Stock Digest